Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin chromophores are endogenous molecules, such as DNA, melanin, urocanic acid, and porphyrins, that absorb specific wavelengths of light to initiate biological responses. In keratinocytes, DNA damage from UV absorption triggers the p53 pathway, leading to the release of alpha-melanocyte-stimulating hormone (alpha-MSH). This hormone binds to the melanocortin 1 receptor (MC1R) on melanocytes to stimulate eumelanin production, providing photoprotection (D'Orazio et al., 2013). Additionally, chromophores like trans-urocanic acid undergo photoisomerization to cis-urocanic acid, which modulates T cell activity and contributes to systemic immunosuppression (Gibbs et al., 2008). While these pathways are essential for protection against radiation, their dysregulation or overexposure to UV leads to skin cancers, photoaging, and inflammatory conditions. Therapeutic interventions often involve exogenous chromophores in photodynamic therapy or protective filters in sunscreens to modulate these interactions.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin chromophores and photobiological signaling pathways.